Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Gestational Diabetes Act of 2019 or the GEDI Act This bill amends the Public Health Service Act to direct the Centers for Disease Control and Prevention (CDC) to develop a multisite gestational diabetes (i.e., diabetes occuring during pregnancy) research project to expand and enhance surveillance data and public health research about gestational diabetes. The CDC must: (1) award grants for demonstration projects to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) work with state and tribal diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and related complications.
Advisory bodiesDigestive and metabolic diseasesHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsSex and reproductive healthWomen's health
GEDI Act
USA116th CongressHR-3109| House
| Updated: 6/6/2019
Gestational Diabetes Act of 2019 or the GEDI Act This bill amends the Public Health Service Act to direct the Centers for Disease Control and Prevention (CDC) to develop a multisite gestational diabetes (i.e., diabetes occuring during pregnancy) research project to expand and enhance surveillance data and public health research about gestational diabetes. The CDC must: (1) award grants for demonstration projects to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) work with state and tribal diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and related complications.
Advisory bodiesDigestive and metabolic diseasesHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsSex and reproductive healthWomen's health